- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
HIV-related deaths and new HIV infections among people who inject drugs could be almost entirely eliminated by 2030 with just a tiny shift in global drug control spending. This is one finding of our report The Case for a Harm Reduction Decade.
The study uses data we have collected over the last 10 years for our biennial Global State of Harm Reduction reports to assess progress and reflect on challenges faced around the world. Using mathematical modelling, it then outlines the potential impact of increased investment in harm reduction on avoidable health-related harms associated with injecting drug use over the next decade and beyond.
The new data in this report shows a worrying slowdown in the provision of harm reduction services for people who use drugs, with no new countries introducing needle and syringe programmes since 2014.
Along with this, there has been a rise in injecting stimulant use across all regions of the world, and a dramatic increase in overdose deaths.
Harm reduction in prisons also remains vastly insufficient, with only a very small number of countries providing needle exchange or overdose training in at least one prison.
Keywords: HIV, PWID, prisoners, drug, OST, NSP, hepatitis C, needle/syringe
The World Drug Report 2016 is published in the wake of the landmark moment in global drug policy, the special session of the General Assembly on the world drug problem. Chapter I provides a global overview of the supply of and demand for opiates, cocaine, cannabis, amphetamine-type stimulants (ATS) and new psychoactive substances (NPS), as well as their impact on health. It also reviews the scientific evidence on polydrug use, treatment demand for cannabis and developments since the legalization of cannabis for recreational use in some parts of the world. Chapter II focuses on the mechanisms of the interaction between the world drug problem and all aspects of sustainable development through the lens of the Sustainable Development Goals.
Indonesia is home to about 74,000 people who inject drugs, of whom 11% are women. Compared with men who inject drugs, women who inject drugs experience an elevated risk of HIV and other blood borne virus transmission, disproportionately high rates of violence from both intimate and non-intimate partners, and social exclusion. Despite their specific needs and greater marginalisation, this group has been largely neglected in Indonesia’s national HIV strategy.
The study explored sexual and injecting behaviours, health indicators, gender-based violence, contact with law enforcement, and uptake of health and support services among women who inject drugs. The broad objective of the study was to better understand the experiences of women who inject drugs and to inform evidence-based responses that can mitigate the impacts of drug use and HIV and AIDS on this vulnerable population in Indonesia.
This is the International Network of People who Use Drugs’ (INPUD) Consensus Statement on Drug Use Under Prohibition. It focusses on human rights, health, and the law in relation to people who use drugs. The document is informed by the perspective of those who are so catastrophically impacted by global prohibition and by the so-called ‘war on drugs’: people who use drugs themselves. It stems from four regional consultations conducted by the INPUD Secretariat in 2015 with representatives of 24 drug user organisations from 28 countries. Consultations took place in Dar es Salaam, Bangkok, London, and in Tbilisi, and we also conducted a virtual consultation.
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India.
Under the leadership of the National Center for AIDS and STD Control (NCASC) according to the National HIV Surveillance Plan for generating the strategic information needed for guiding and monitoring the national response to HIV and AIDS, since 2002 Nepal has been successfully carrying out IBBS surveys among People Who Inject Drugs (PWIDs).
This is the sixth round of the IBBS survey conducted among People Who Inject Drugs (PWID) in Eastern Terai. In line with the objectives of the previous rounds of the IBBS, this survey was also undertaken primarily to determine trends of HIV and STIs, HIV and STI related risk behaviours, drug injecting behaviours, the level of awareness about HIV/STIs and exposure to HIV intervention programs among PWID in Eastern Terai. Moreover, this survey examined the prevalence of Hepatitis B and Hepatitis C among PWID for the first time. Fieldwork for data collection was conducted in July, 2015.
Keywords: Nepal, Eastern Terai, HIV, IBBS, PWID, condom, prevalence, syphilis
Although global coverage of harm reduction services has slowly increased, there is a lack of services focused on and accessible to young people, despite low ages of initiation into injecting drug use in many countries and important differences in vulnerability and risk between younger and older people who inject drugs.
Keywords: HIV, young women, violence, harassment, stigma and discrimination, law and policy
This is the sixth round of the IBBS study conducted among PWIDs in Eastern Terai Highway Districts. This survey is a part of the National HIV Surveillance Plan (2012) and National HIV and AIDS Strategy (2011-2016). In line with the objectives of the previous rounds of the IBBS, the sixth round of the survey was also undertaken primarily to determine the prevalence of HIV and STIs, assess HIV and STI related risk behaviours, drug injecting behaviours, the level of awareness about HIV/STIs, as well as their exposure to intervention programs among PWIDs in Eastern Terai Highway Districts. Moreover, this survey examined the prevalence of Hepatitis B and Hepatitis C among PWIDs for the first time.
Keywords: Nepal, Eastern Terai Highway, HIV, STI, Hepatitis B and Hepatitis C, needles/syringe, treatment, condom use, testing, stigma and discrimination